陶罗利丁和肝素作为用于血液透析中的中央静脉导管的导管锁溶液
Timothy Nguyen1, Bernard C Camins2, David A Butler3
1Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY.
塔罗利丁和肝素导管锁液显著减少了血液透析患者的导管相关血流感染 (CRBSI). 这种新的方法为预防需要中央静脉导管 (CVC) 的患者的CRBSI提供了抗菌疗法更安全的替代方案.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
- 医疗器械 医疗器械
背景情况:
- 末期病的患病率越来越高,需要进行血液透析,通常需要使用中央静脉导管 (CVC).
- 导管相关的血流感染 (CRBSI) 是血液透析患者患病和死亡的重要原因.
- 现有的CRBSI预防方法,如抗微生物锁定疗法,引起了人们对耐药性和不良影响的担忧.
研究的目的:
- 为了评估taurolidine和heparin导管锁溶液在预防血液透析患者的CRBSIs中的有效性.
- 评估这种新型非抗菌性消毒锁液的安全性和有效性.
主要方法:
- 一项随机,双盲,第三期研究 (LOCK-IT-100试验) 涉及795名末期病患者,接受血液透析和CVCs.
- 塔罗利丁和肝素锁定溶液与单独的肝素作为对照剂的比较.
- 锁定溶液的内使用,然后吸入.
主要成果:
- 与单独使用肝素相比,陶罗利丁和肝素锁定溶液显示CRBSI风险降低了71% (P = 0.0006).
- 其他研究和系统性审查中一致的发现表明,在成人和儿科患者中,使用taurolidine锁定溶液减少了CRBSI发病率.
- 该溶液具有抗微生物和抗凝固特性,防止微生物损伤和生物膜形成.
结论:
- 陶罗利丁和氨酸导管锁液是一种新且有效的预防策略,用于血液透析患者的CRBSI.
- 这代表了显著的治疗进步,提供了一个有价值的选择,CVCs对于挽救生命的治疗至关重要.
- 罗利丁的独特作用机制和良好的安全性概况使其成为传统抗微生物锁定疗法的有希望的替代品.
更多相关视频
08:51Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
Published on: March 31, 2023
09:38Femoral Arterial and Venous Catheterization for Blood Sampling, Drug Administration and Conscious Blood Pressure and Heart Rate Measurements
Published on: January 24, 2012
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
